Compounds > catechin

catechin and Bone Neoplasms

catechin has been researched along with Bone Neoplasms in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (30.77)29.6817
2010's7 (53.85)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Chen, Y; Dong, C; Shen, P; Wang, H; Wang, J; Wang, Z1
Chen, J; Dong, X; Gu, C; Gui, M; Jin, W; Shan, L; Yang, X; Yuan, Q; Zhang, J; Zhou, L1
Chen, D; Wang, W; Zhu, K1
Dong, X; Efferth, T; Jin, W; Li, C; Liu, F; Shan, L; Tong, P; Xie, L; Xu, Y; Yan, B; Yan, L; Yu, W; Yuan, Q; Zhang, J; Zhou, L1
He, A; He, X; Jiang, L; Tao, C1
Chen, B; Chen, J; Chen, X; Chen, Y; Qian, H; Tang, G; Wang, Y; Zhang, Z1
Li, Q; Zhang, X1
Castillo-Pichardo, L; Cubano, LA; Dharmawardhane, S; Martínez, JE; Martínez-Montemayor, MM; Wall, KM1
Guo, W; Han, X; Lu, XC; Peng, CL; Ren, TT; Tang, GQ; Yan, TQ; Zhao, FL; Zhao, H1
Jenabi, JM; Kang, HG; Liu, XF; Reynolds, CP; Sorensen, PH; Triche, TJ1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW1
Axanova, L; Morré, DJ; Morré, DM1
Goldberg, VM; Haqqi, TM; Islam, N; Islam, S; Johnstone, B; Kermode, T; Malemud, CJ; Moskowitz, RW; Mukhtar, H1

Other Studies

13 other study(ies) available for catechin and Bone Neoplasms

ArticleYear
Epigallocatechin-3-gallate suppresses the growth of human osteosarcoma by inhibiting the Wnt/β-catenin signalling pathway.
    Bioengineered, 2022, Volume: 13, Issue:4

    Topics: Animals; Apoptosis; beta Catenin; Bone Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Osteosarcoma; Wnt Signaling Pathway

2022
Theabrownin inhibits the cytoskeleton‑dependent cell cycle, migration and invasion of human osteosarcoma cells through NF‑κB pathway‑related mechanisms.
    Oncology reports, 2020, Volume: 44, Issue:6

    Topics: Animals; Bone Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Down-Regulation; Embryo, Nonmammalian; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; NF-kappa B; Osteosarcoma; RNA-Seq; Signal Transduction; Xenograft Model Antitumor Assays; Zebrafish

2020
SOX2OT variant 7 contributes to the synergistic interaction between EGCG and Doxorubicin to kill osteosarcoma via autophagy and stemness inhibition.
    Journal of experimental & clinical cancer research : CR, 2018, Feb-23, Volume: 37, Issue:1

    Topics: Animals; Apoptosis; Autophagy; Biomarkers; Bone Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Self Renewal; Disease Models, Animal; Doxorubicin; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Neoplastic Stem Cells; Osteosarcoma; Receptor, Notch3; RNA, Long Noncoding; Xenograft Model Antitumor Assays

2018
Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:9

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Caspase 3; Catechin; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; DNA Damage; Gene Expression Regulation, Neoplastic; Histones; Humans; Ki-67 Antigen; Larva; Mesenchymal Stem Cells; Osteoblasts; Osteosarcoma; Poly(ADP-ribose) Polymerases; RNA, Small Interfering; Signal Transduction; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; Zebrafish

2018
Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate.
    World journal of surgical oncology, 2014, Dec-16, Volume: 12

    Topics: Apoptosis; Bone Neoplasms; Catechin; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Humans; MicroRNAs; Osteosarcoma; Tumor Cells, Cultured

2014
(-)-Epigallocatechin-3-gallate inhibits osteosarcoma cell invasiveness by inhibiting the MEK/ERK signaling pathway in human osteosarcoma cells.
    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer, 2015, Volume: 34, Issue:1

    Topics: Bone Neoplasms; Catechin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Osteosarcoma

2015
Epigallocatechin-3-gallate attenuates bone cancer pain involving decreasing spinal Tumor Necrosis Factor-α expression in a mouse model.
    International immunopharmacology, 2015, Volume: 29, Issue:2

    Topics: Animals; Behavior, Animal; Bone Neoplasms; Catechin; Disease Progression; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Osteosarcoma; Pain Measurement; Pain, Intractable; Spinal Cord; Spine; Tumor Necrosis Factor-alpha

2015
Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols.
    Clinical & experimental metastasis, 2009, Volume: 26, Issue:6

    Topics: Animals; Apoptosis; Bone Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Mice; NF-kappa B; Quercetin; Resveratrol; Stilbenes; Vitis

2009
(-)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells.
    Journal of cancer research and clinical oncology, 2010, Volume: 136, Issue:8

    Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Catechin; Cell Death; Cell Division; Cell Survival; Chondrosarcoma; DNA Primers; Flow Cytometry; Gene Amplification; Humans; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface

2010
Inhibition of the insulin-like growth factor I receptor by epigallocatechin gallate blocks proliferation and induces the death of Ewing tumor cells.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:5

    Topics: Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Catechin; Cell Adhesion; Cell Death; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Evaluation, Preclinical; Humans; MAP Kinase Signaling System; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphorylation; Receptor, IGF Type 1; Sarcoma, Ewing

2010
Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
    Oncology reports, 2005, Volume: 13, Issue:2

    Topics: Arginine; Ascorbic Acid; Bone Neoplasms; Catechin; Cell Proliferation; Dose-Response Relationship, Drug; Humans; Lysine; Matrix Metalloproteinases; Neovascularization, Pathologic; Nutritional Physiological Phenomena; Osteosarcoma; Proline; Sarcoma, Ewing; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005
Growth of LNCaP cells in monoculture and coculture with osteoblasts and response to tNOX inhibitors.
    Cancer letters, 2005, Jul-08, Volume: 225, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Bone Neoplasms; Capsaicin; Catechin; Cell Survival; Cisplatin; Humans; Isoflavones; Male; Osteoblasts; Paclitaxel; Plant Extracts; Prostatic Neoplasms; Tumor Cells, Cultured

2005
Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells.
    Biochemical and biophysical research communications, 2000, Apr-21, Volume: 270, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Caspase 3; Caspases; Catechin; Cell Survival; Chondrosarcoma; Cysteine Proteinase Inhibitors; Humans; Kinetics; Tumor Cells, Cultured

2000